146 related articles for article (PubMed ID: 16252076)
1. The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes.
Drukarch B; Flier J; Jongenelen CA; Andringa G; Schoffelmeer AN
J Neural Transm (Vienna); 2006 May; 113(5):593-8. PubMed ID: 16252076
[TBL] [Abstract][Full Text] [Related]
2. Anethole dithiolethione, a putative neuroprotectant, increases intracellular and extracellular glutathione levels during starvation of cultured astroglial cells.
Dringen R; Hamprecht B; Drukarch B
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):616-22. PubMed ID: 9879719
[TBL] [Abstract][Full Text] [Related]
3. Anethole dithiolethione prevents oxidative damage in glutathione-depleted astrocytes.
Drukarch B; Schepens E; Stoof JC; Langeveld CH
Eur J Pharmacol; 1997 Jun; 329(2-3):259-62. PubMed ID: 9226421
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase-A physically interacts with presenilin-1(M146V) in the mouse cortex.
Wei Z; Gabriel GG; Rui L; Cao X; Pennington PR; Chlan-Fourney J; Nazarali AJ; Baker GB; Mousseau DD
J Alzheimers Dis; 2012; 28(2):403-22. PubMed ID: 22045496
[TBL] [Abstract][Full Text] [Related]
5. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
[TBL] [Abstract][Full Text] [Related]
6. 2,2'-Dithienyl diselenide, an organoselenium compound, elicits antioxidant action and inhibits monoamine oxidase activity in vitro.
Bortolatto CF; Chagas PM; Wilhelm EA; Zeni G; Nogueira CW
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):677-84. PubMed ID: 22468748
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
Guang HM; Du GH
Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097
[TBL] [Abstract][Full Text] [Related]
8. Differences in monoamine oxidase activity between cultured noradrenergic and cholinergic sympathetic neurons.
Pintar JE; Breakefield XO; Patterson PH
Dev Biol; 1987 Mar; 120(1):305-8. PubMed ID: 3817298
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase B (MAO-B) inhibition by active principles from Uncaria rhynchophylla.
Hou WC; Lin RD; Chen CT; Lee MH
J Ethnopharmacol; 2005 Aug; 100(1-2):216-20. PubMed ID: 15890481
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
11. 1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease.
Chung JY; Lee JW; Ryu CH; Min HK; Yoon YJ; Lim MJ; Park CH
J Neurosci Res; 2015 Aug; 93(8):1267-78. PubMed ID: 25711470
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
[TBL] [Abstract][Full Text] [Related]
13. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
Herraiz T; Arán VJ; Guillén H
Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Fisar Z; Hroudová J; Raboch J
Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
Prins LH; Petzer JP; Malan SF
Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase inhibitory coumarin from Zanthoxylum schinifolium.
Jo YS; Huong DT; Bae K; Lee MK; Kim YH
Planta Med; 2002 Jan; 68(1):84-5. PubMed ID: 11842339
[TBL] [Abstract][Full Text] [Related]
17. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells.
Mazzio EA; Harris N; Soliman KF
Planta Med; 1998 Oct; 64(7):603-6. PubMed ID: 9810264
[TBL] [Abstract][Full Text] [Related]
18. A scaffold hopping approach to identify novel monoamine oxidase B inhibitors.
Geldenhuys WJ; Funk MO; Van der Schyf CJ; Carroll RT
Bioorg Med Chem Lett; 2012 Feb; 22(3):1380-3. PubMed ID: 22225638
[TBL] [Abstract][Full Text] [Related]
19. Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant.
Seif-El-Nasr M; Atia AS; Abdelsalam RM
Arzneimittelforschung; 2008; 58(4):160-7. PubMed ID: 18540477
[TBL] [Abstract][Full Text] [Related]
20. 3-Coumaranone derivatives as inhibitors of monoamine oxidase.
Van Dyk AS; Petzer JP; Petzer A; Legoabe LJ
Drug Des Devel Ther; 2015; 9():5479-89. PubMed ID: 26491258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
